Endeavour Vision

Oncoethix SA is a private Swiss company that was founded in 2007 by Esteban Cvitkovic, MD, Kay Noel, PhD, Yves Paternot, and Patrice Herait, MD (all former associates at Cvitkovic & Associes Consultants SA) to develop a portfolio of 3 to 5 promising new drugs for cancer treatment. The company intends to develop its compounds through clinical proof of concept and the identification of an expedited registration strategy, after which pharmaceutical partners will be sought to fund pivotal trials and handle commercialization. Oncoethix founders have an unsurpassed track record in identifying and bringing oncology leads to global markets. Dr. Cvitkovic, Chief Scientific Officer for Oncoethix, led the clinical development of single agent and combination regimens for cisplatin, vindesine, bleomycin, navelbine, and, more recently, irinotecan, oxaliplatin, docetaxel, and trabectedin, first as an academic investigator and then through a specialized oncology clinical research organization. Prior to founding Oncoethix and assuming responsibilities as Chief Operating Officer, Dr. Noel had co-founded another oncology drug development company which in-licensed oxaliplatin as its first portfolio product and subsequently identified, evaluated, and in-licensed novel agents for several clients. Additionally, Dr. Noel has developed expedited registration strategies for many cancer drugs and registration files for a few of these. Dr. Herait managed clinical development of irinotecan, from Phase 1 through Phase 3, while at Rhone Poulenc Rorer and subsequently, as a consultant, managed clinical studies for several novel cancer drugs. Since its founding, Oncoethix has in-licensed three promising cancer drug candidates, each a first-in-class agent to a novel target or with a novel mode of action. Currently, two portfolio compounds are in clinical development. Oncoethix was launched with an initial financing of 1.30 million Swiss francs from the founders to finance portfolio development. In December 2009, the company closed a Series A financing of 3.7 million Swiss francs with leading venture capital firms Index Ventures and Endeavour Vision.

Symetis is a Swiss Company developing innovative minimally invasive heart valve replacement therapies for patients suffering from heart valve diseases. Symetis is dedicated to improving patient care and safety by offering simple, accurate solutions for heart valve replacement. Its proprietary Acurateâ„¢Aortic Valve Replacement System features a unique self-positioning design providing facile implant positioning and alignment as well as unrivalled ease of use.

V-Wave Ltd. develops percutaneous implantable therapeutic devices for chronic heart failure patients. It offers V-Wave Shunt, a biocompatible inter-atrial unidirectional implant that is used to treat chronic heart failure patients with preserved and reduced ejection fraction (diastolic and systolic heart failure). The company was founded in 2009 and is based in Caesarea, Israel with additional offices in Israel and the United States.

Gynesonics, Inc. designs and develops minimally invasive solutions for symptomatic uterine fibroids in women. The company offers Sonography-Guided Transcervical Fibroid Ablation (Sonata) System(The Sonata System) for the transcervical treatment of symptomatic uterine fibroids under intrauterine sonography guidance serving customers in the European Union. Gynesonics, Inc. was founded in 2005 and is based in Redwood City, California with an additional location in Beuningen, the Netherlands.

Lumeon Ltd., a digital health company, provides care pathway management solutions to the healthcare industry. The company offers Care Pathway Manager, a cloud-based platform that provides a single real-time view of patient journey from referral to outcome. Its services include business analysis, project management, configuration and data migration, training, and support. Lumeon Ltd. was formerly known as Qinec Ltd. and changed its name to Lumeon Ltd. in July 2016. The company was founded in 2005 and is based in London, United Kingdom.

CXignited sets the new standard for Customer Experience (CX) igniting product, people and brand passion. Through its progressive ShopCX Cloud Platform, CXignited streams shop floor and Unified Commerce information intelligence through RFID/Beacons/IoT. With a Real-time Local Positioning System (RLPS), CXignited drives product digitalization, localization, personalization and authentication across the Omni-channel for luxury retailers and global brands.

Swift Health Systems Inc., a medical device company, develops invisible orthodontic solutions. The company develops InBrace, an orthodontic system that is hidden behind the teeth to correct malocclusion (crooked teeth). Swift Health Systems Inc. was incorporated in 2014 and is based in Irvine, California.

Willow is a female technology company that develops an in-bra wearable breast pump. Its breast pumps are cordless and spill-proof. It also tracks milk output through a mobile application along with an online portal, enabling mothers to pump anywhere without hassle. The company was founded in 2014 and is headquartered in Mountain View, California.

Polares Medical S.A. manufactures and markets medical device to reduce or eliminate mitral valve regurgitation. The company is based in Ecublens, Switzerland, with additional office in Palo Alto, California.

SmallRivers develops web services that are facilitating the interconnection of people around shared interests. SmallRivers is a privately held startup incorporated in Switzerland (Lausanne) and located on the Swiss Federal Institute of Technology EPFL campus, Scientific Park.

Nuvaira, Inc. develops medical devices to treat obstructive lung diseases. It offers Lung Denervation System, a novel, catheter-based system designed to treat airway nerve hyperactivity and to address chronic obstructive pulmonary diseases by treating overactive airway nerves during a minimally invasive procedure that targets the parasympathetic innervation of the lungs. Nuvaira, Inc. was formerly known as Holaira, Inc. and changed its name to Nuvaira, Inc. in June 2017. The company was incorporated in 2008 and is based in Minneapolis, Minnesota.

IntelyCare offers a digital workforce augmentation platform that combines a gig-model application with advanced data science to optimize staff resources and close the widening gap between workforce supply and demand. IntelyCare is revolutionizing the antiquated healthcare staffing market, filling nursing shifts at three times the industry average and giving post-acute facilities the tools to predict and manage staffing needs. The company’s engaging mobile app empowers nursing professionals with access to flexible, on-demand work opportunities, reducing burnout and attrition while increasing productivity.

Full-service provider in the prepaid and gift card industry and leading network for the distribution of gift cards in continental Europe.

CeQur SA is dedicated to developing and commercializing advanced insulin delivery systems that make it easier for people living with type 2 diabetes to comply with therapy and stay in control of their disease. CeQur is developing the CeQurâ„¢ Insulin Infuser, a simple and discrete insulin delivery tool for people who could benefit from intensive insulin therapy but want flexibility and freedom from multiple daily injections. CeQur was established in January 2008 as a spin out from Danfoss A/S, a large, global Danish industrial products group. The company is headquartered in Montreux, Switzerland, with operations in Nordborg, Denmark and Marlborough, Massachusetts.

Molecular Partners is a clinical-stage biopharmaceutical company working to advance modern medicine and significantly improve the management of serious diseases. They are developing a powerful new class of potent, specific and versatile small protein therapies called DARPin® therapeutics.

CeQur SA is dedicated to developing and commercializing advanced insulin delivery systems that make it easier for people living with type 2 diabetes to comply with therapy and stay in control of their disease. CeQur is developing the CeQurâ„¢ Insulin Infuser, a simple and discrete insulin delivery tool for people who could benefit from intensive insulin therapy but want flexibility and freedom from multiple daily injections. CeQur was established in January 2008 as a spin out from Danfoss A/S, a large, global Danish industrial products group. The company is headquartered in Montreux, Switzerland, with operations in Nordborg, Denmark and Marlborough, Massachusetts.

VentureMed Group (VMG) designs, develops and markets innovative medical devices which enable interventionalists to cost effectively treat peripheral artery diseases and improve the lives of their patients. Founded by physicians who understand the clinical, medical and financial demands in today’s healthcare environment, VMG creates truly cost effective solutions. Their flagship product, the FLEX Scoring Catheter enables providers to reduce expensive inventory costs while offering the interventionalist more treatment options from a single device.

Lumavita AG, a biopharmaceutical company, engages in the development and commercialization of novel anti-infectives for women's health. Its products include FemiFect, an antibiotic to treat infections known to cause vaginitis, such as bacteria, fungi, and protozoa; and SPK-601 that is for the treatment of human papilloma virus (HPV) and herpes simplex virus (HSV). The company markets its products through distributors. Lumavita AG was formerly known as Shogoo Pharmaceuticals, AG and changed its name to Lumavita AG in December, 2007. The company was founded in 2008 and is based in Basel, Switzerland. Lumavita AG operates as a subsidiary of Shogoo Pharmaceuticals KK.

Kobojo is a French startup that was created in 2008. Kobojo was created to give a social dimension to classical games and online applications, for we love games, most particularly when we can play with friends ! Games for social networks provide much more fun, and a more interesting user experience, for your adversaries are usually people you know ! Kobojo proposes games and applications for social networks, and facilitates the connection between players, for people to play with friends they have not seen for a long time, for instance. Moreover Kobojo’s applications don’t need to be downloaded. Kobojo proposes games for everyone, and despite our games are currently only availabe on Facebook and iPhone, we will soon offer you to play on MySpace, Bebo, Hi5 and many other social networks !

Relievant Medsystems, Inc., a medical device company, develops a minimally invasive procedure for treatment of chronic axial low back pain. It develops Intracept, a procedure that targets the basivertebral nerve for the relief of chronic vertebrogenic low back pain. The company was incorporated in 2004 and is based in Minneapolis, Minnesota with a development and operations office in Sunnyvale, California.

Quid, Inc. develops a platform that searches, analyzes, and visualizes the collective intelligence to answer strategic questions. It offers Quid, a platform that ingests the ideas and opinions expressed in written language to find patterns and commonalities across various documents. The company’s Quid calculates, collects, and stores datasets for patents, companies, and various news and blog sources. It serves marketing/PR agencies, consulting, technology, healthcare, and financial services markets. The company was founded in 2006 and is based in San Francisco, California with additional offices in New York, New York; and London, United Kingdom. As per the transaction announced on January 28, 2020, Quid, Inc. was acquired by NetBase Solutions, Inc.

ReShape Medical Inc. provides a non-surgical weight loss procedure that helps people to lose weight. The company’s ReShape procedure combines two intragastric balloons with a one-year personalized weight loss program to help patients with mild to moderate obesity (BMI 30-40). The company’s ReShape is provided at medical weight loss centers. ReShape Medical Inc. was formerly known as Abdominis, Inc. The company was founded in 2005 and is based in San Clemente, California. As of October 2, 2017, ReShape Medical Inc. operates as a subsidiary of EnteroMedics Inc.

Rapid Micro Biosystems provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. It offers the Growth Direct System, a non-destructive method for microbial enumeration. The company was formerly known as Genomic Profiling Systems and changed its name to Rapid Micro Biosystems in 2007. Rapid Micro Biosystems was founded in 2006 and is based in Bedford, Massachusetts.

Full-service provider in the prepaid and gift card industry and leading network for the distribution of gift cards in continental Europe.

Nalu Medical is an early-stage company that develops a range of medical devices. Their vision to modernize and improve the technology in medical devices, thus improving the lives of people. The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The company was founded in 2014 and is based in Carlsbad, California.

Gynesonics, Inc. designs and develops minimally invasive solutions for symptomatic uterine fibroids in women. The company offers Sonography-Guided Transcervical Fibroid Ablation (Sonata) System(The Sonata System) for the transcervical treatment of symptomatic uterine fibroids under intrauterine sonography guidance serving customers in the European Union. Gynesonics, Inc. was founded in 2005 and is based in Redwood City, California with an additional location in Beuningen, the Netherlands.

Virtual Incision is the pioneer of in vivo mini-robot surgery, enabling minimally-invasive colon resection and other abdominal procedures. Colorectal cancer is the second-deadliest form of the disease, and along with conditions like Diverticulitis and Crohn’s, treatment often requires a colectomy, almost 400,000 of which are performed each year in the U.S. alone. Two-thirds of these procedures are still performed open, requiring a long, gruesome incision. VIC’s simpler/easier/cheaper approach is to insert a mini-robot into the insufflated abdomen via a small umbilical incision, after which the highly-dextrous robot arms are freely manipulated at the nearby surgeon console. VIC enables MIS colectomy using well-known laparoscopic tools, onboard vision, and leading multi-quadrant capabilities. After 70+ pig labs and with 60+ patents/applications, VIC is seeking a $15M Series B financing to achieve First-in-Man and prepare for CE Mark and FDA 510(k) submissions.

V-Wave Ltd. develops percutaneous implantable therapeutic devices for chronic heart failure patients. It offers V-Wave Shunt, a biocompatible inter-atrial unidirectional implant that is used to treat chronic heart failure patients with preserved and reduced ejection fraction (diastolic and systolic heart failure). The company was founded in 2009 and is based in Caesarea, Israel with additional offices in Israel and the United States.

Relievant Medsystems, Inc., a medical device company, develops a minimally invasive procedure for treatment of chronic axial low back pain. It develops Intracept, a procedure that targets the basivertebral nerve for the relief of chronic vertebrogenic low back pain. The company was incorporated in 2004 and is based in Minneapolis, Minnesota with a development and operations office in Sunnyvale, California.

Kestra Medical Technologies, Inc. develops and manufactures wearable medical devices for monitoring and managing acute medical conditions. The company provides wearable solutions to collect, communicate, and store patient performance data, with real-time and retrospective analysis. Additionally, it offers wearable cardioverter defibrillators to prevent sudden cardiac death and assist cardiac recovery in at-risk patients. Kestra Medical Technologies, Inc. was founded in 2014 and is headquartered in Kirkland, Washington.

Molecular Partners is a clinical-stage biopharmaceutical company working to advance modern medicine and significantly improve the management of serious diseases. They are developing a powerful new class of potent, specific and versatile small protein therapies called DARPin® therapeutics.

Symetis is a Swiss Company developing innovative minimally invasive heart valve replacement therapies for patients suffering from heart valve diseases. Symetis is dedicated to improving patient care and safety by offering simple, accurate solutions for heart valve replacement. Its proprietary Acurateâ„¢Aortic Valve Replacement System features a unique self-positioning design providing facile implant positioning and alignment as well as unrivalled ease of use.

Amplidata N.V. offers AmpliStor, an object-based software defined storage solution for enterprise, private cloud, and public cloud implementations in various industries in Belgium and internationally. The company offers Himalaya Service Provider and OEM Edition software, a customizable platform for service provider and OEM-built storage services and solutions; and Himalaya Enterprise Edition software, which provides users with control over their data. It also offers a range of appliances that include the AmpliStor software with servers, as well as controllers and storage nodes connected through a standard switched Ethernet fabric. In addition, the company provides support and professional services for large enterprises, service provides, and distributed government organizations. It offers solutions for cloud services, life sciences, media and entertainment, oil and gas, online applications, digital library, video surveillance, government, and Fortune 500 enterprises. Amplidata N.V. has a strategic partnership with Western Digital Capital. The company was founded in 2008 and is based in Lochristi, Belgium with an additional headquarters in Milpitas, California. It also has support centers in the United States, Belgium, and Taiwan. Amplidata N.V. operates as a subsidiary of HGST Netherlands B.V.

VentureMed Group (VMG) designs, develops and markets innovative medical devices which enable interventionalists to cost effectively treat peripheral artery diseases and improve the lives of their patients. Founded by physicians who understand the clinical, medical and financial demands in today’s healthcare environment, VMG creates truly cost effective solutions. Their flagship product, the FLEX Scoring Catheter enables providers to reduce expensive inventory costs while offering the interventionalist more treatment options from a single device.

CXignited sets the new standard for Customer Experience (CX) igniting product, people and brand passion. Through its progressive ShopCX Cloud Platform, CXignited streams shop floor and Unified Commerce information intelligence through RFID/Beacons/IoT. With a Real-time Local Positioning System (RLPS), CXignited drives product digitalization, localization, personalization and authentication across the Omni-channel for luxury retailers and global brands.

Nuvaira, Inc. develops medical devices to treat obstructive lung diseases. It offers Lung Denervation System, a novel, catheter-based system designed to treat airway nerve hyperactivity and to address chronic obstructive pulmonary diseases by treating overactive airway nerves during a minimally invasive procedure that targets the parasympathetic innervation of the lungs. Nuvaira, Inc. was formerly known as Holaira, Inc. and changed its name to Nuvaira, Inc. in June 2017. The company was incorporated in 2008 and is based in Minneapolis, Minnesota.

CeQur SA is dedicated to developing and commercializing advanced insulin delivery systems that make it easier for people living with type 2 diabetes to comply with therapy and stay in control of their disease. CeQur is developing the CeQurâ„¢ Insulin Infuser, a simple and discrete insulin delivery tool for people who could benefit from intensive insulin therapy but want flexibility and freedom from multiple daily injections. CeQur was established in January 2008 as a spin out from Danfoss A/S, a large, global Danish industrial products group. The company is headquartered in Montreux, Switzerland, with operations in Nordborg, Denmark and Marlborough, Massachusetts.

SOPHiA GENETICS combines deep expertise in life sciences and medical disciplines with mathematical capabilities in data computing. The company aims to bring data analytics solutions to the market, to support healthcare professionals by maximizing the power of data-driven medicine. It achieves this mission through the adoption of SOPHiA AI, which is built using techniques such as statistical inference, pattern recognition, and machine learning. This enables SOPHiA to provide equal benefits to all users, unite experts in a gold standard health-tech platform, and motivate expert knowledge sharing for a sustainable impact on future patients. It contributes to making the global healthcare system more sustainable. By helping healthcare professionals leverage their expertise and work together as a community, patients can receive equal access to better diagnoses and treatments. It combines the first two pillars of data-driven medicine, genomics, and radionics, the company ensures that the data used to help patients. Founded by Jurgi Camblong, Lars Steinmetz, and Pierre Hutter, SOPHiA GENETICS was incorporated in 2011. It has offices in Boston, Massachusetts, Switzerland, and France.

Rapid Micro Biosystems provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. It offers the Growth Direct System, a non-destructive method for microbial enumeration. The company was formerly known as Genomic Profiling Systems and changed its name to Rapid Micro Biosystems in 2007. Rapid Micro Biosystems was founded in 2006 and is based in Bedford, Massachusetts.

CXignited sets the new standard for Customer Experience (CX) igniting product, people and brand passion. Through its progressive ShopCX Cloud Platform, CXignited streams shop floor and Unified Commerce information intelligence through RFID/Beacons/IoT. With a Real-time Local Positioning System (RLPS), CXignited drives product digitalization, localization, personalization and authentication across the Omni-channel for luxury retailers and global brands.

IntelyCare offers a digital workforce augmentation platform that combines a gig-model application with advanced data science to optimize staff resources and close the widening gap between workforce supply and demand. IntelyCare is revolutionizing the antiquated healthcare staffing market, filling nursing shifts at three times the industry average and giving post-acute facilities the tools to predict and manage staffing needs. The company’s engaging mobile app empowers nursing professionals with access to flexible, on-demand work opportunities, reducing burnout and attrition while increasing productivity.

Amplidata N.V. offers AmpliStor, an object-based software defined storage solution for enterprise, private cloud, and public cloud implementations in various industries in Belgium and internationally. The company offers Himalaya Service Provider and OEM Edition software, a customizable platform for service provider and OEM-built storage services and solutions; and Himalaya Enterprise Edition software, which provides users with control over their data. It also offers a range of appliances that include the AmpliStor software with servers, as well as controllers and storage nodes connected through a standard switched Ethernet fabric. In addition, the company provides support and professional services for large enterprises, service provides, and distributed government organizations. It offers solutions for cloud services, life sciences, media and entertainment, oil and gas, online applications, digital library, video surveillance, government, and Fortune 500 enterprises. Amplidata N.V. has a strategic partnership with Western Digital Capital. The company was founded in 2008 and is based in Lochristi, Belgium with an additional headquarters in Milpitas, California. It also has support centers in the United States, Belgium, and Taiwan. Amplidata N.V. operates as a subsidiary of HGST Netherlands B.V.

Amplidata N.V. offers AmpliStor, an object-based software defined storage solution for enterprise, private cloud, and public cloud implementations in various industries in Belgium and internationally. The company offers Himalaya Service Provider and OEM Edition software, a customizable platform for service provider and OEM-built storage services and solutions; and Himalaya Enterprise Edition software, which provides users with control over their data. It also offers a range of appliances that include the AmpliStor software with servers, as well as controllers and storage nodes connected through a standard switched Ethernet fabric. In addition, the company provides support and professional services for large enterprises, service provides, and distributed government organizations. It offers solutions for cloud services, life sciences, media and entertainment, oil and gas, online applications, digital library, video surveillance, government, and Fortune 500 enterprises. Amplidata N.V. has a strategic partnership with Western Digital Capital. The company was founded in 2008 and is based in Lochristi, Belgium with an additional headquarters in Milpitas, California. It also has support centers in the United States, Belgium, and Taiwan. Amplidata N.V. operates as a subsidiary of HGST Netherlands B.V.

Quid, Inc. develops a platform that searches, analyzes, and visualizes the collective intelligence to answer strategic questions. It offers Quid, a platform that ingests the ideas and opinions expressed in written language to find patterns and commonalities across various documents. The company’s Quid calculates, collects, and stores datasets for patents, companies, and various news and blog sources. It serves marketing/PR agencies, consulting, technology, healthcare, and financial services markets. The company was founded in 2006 and is based in San Francisco, California with additional offices in New York, New York; and London, United Kingdom. As per the transaction announced on January 28, 2020, Quid, Inc. was acquired by NetBase Solutions, Inc.

SOPHiA GENETICS combines deep expertise in life sciences and medical disciplines with mathematical capabilities in data computing. The company aims to bring data analytics solutions to the market, to support healthcare professionals by maximizing the power of data-driven medicine. It achieves this mission through the adoption of SOPHiA AI, which is built using techniques such as statistical inference, pattern recognition, and machine learning. This enables SOPHiA to provide equal benefits to all users, unite experts in a gold standard health-tech platform, and motivate expert knowledge sharing for a sustainable impact on future patients. It contributes to making the global healthcare system more sustainable. By helping healthcare professionals leverage their expertise and work together as a community, patients can receive equal access to better diagnoses and treatments. It combines the first two pillars of data-driven medicine, genomics, and radionics, the company ensures that the data used to help patients. Founded by Jurgi Camblong, Lars Steinmetz, and Pierre Hutter, SOPHiA GENETICS was incorporated in 2011. It has offices in Boston, Massachusetts, Switzerland, and France.

Herzsache GmbH provides heart care services to patients at home. Herzsache GmbH is headquartered in Altdorf Bei Nurnberg, Germany.

Nalu Medical is an early-stage company that develops a range of medical devices. Their vision to modernize and improve the technology in medical devices, thus improving the lives of people. The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The company was founded in 2014 and is based in Carlsbad, California.

Polares Medical S.A. manufactures and markets medical device to reduce or eliminate mitral valve regurgitation. The company is based in Ecublens, Switzerland, with additional office in Palo Alto, California.

Lumeon Ltd., a digital health company, provides care pathway management solutions to the healthcare industry. The company offers Care Pathway Manager, a cloud-based platform that provides a single real-time view of patient journey from referral to outcome. Its services include business analysis, project management, configuration and data migration, training, and support. Lumeon Ltd. was formerly known as Qinec Ltd. and changed its name to Lumeon Ltd. in July 2016. The company was founded in 2005 and is based in London, United Kingdom.

CommProve develops real-time Quality of Service (QoS) monitoring for wireless networks. CommProve was founded in 1996 by specialists in network operations and advanced software engineering. Their initial Tier 1 customer engagements, involving GSM network deployment, identified a need for efficiently measuring, analyzing and reporting the quality of the subscriber’s experience as delivered by the radio link.

Chrono Therapeutics Inc., a digital transdermal drug delivery company, develops SmartStop, a digital nicotine replacement therapy. Its wearable solution tailors the timing and dose sizes of drugs, preempts predictable peak disease, and addiction symptoms with a device. The company was incorporated in 2003 and is based in Hayward, California.

V-Wave Ltd. develops percutaneous implantable therapeutic devices for chronic heart failure patients. It offers V-Wave Shunt, a biocompatible inter-atrial unidirectional implant that is used to treat chronic heart failure patients with preserved and reduced ejection fraction (diastolic and systolic heart failure). The company was founded in 2009 and is based in Caesarea, Israel with additional offices in Israel and the United States.

Polares Medical S.A. manufactures and markets medical device to reduce or eliminate mitral valve regurgitation. The company is based in Ecublens, Switzerland, with additional office in Palo Alto, California.

V-Wave Ltd. develops percutaneous implantable therapeutic devices for chronic heart failure patients. It offers V-Wave Shunt, a biocompatible inter-atrial unidirectional implant that is used to treat chronic heart failure patients with preserved and reduced ejection fraction (diastolic and systolic heart failure). The company was founded in 2009 and is based in Caesarea, Israel with additional offices in Israel and the United States.

EndoStim, Inc., a medical device company, develops and commercializes neurostimulation solutions for the treatment of gastro-esophageal reflux disease (GERD). Its solutions cover treatment for GERD through electrical stimulation. The company distributes its products throughout Europe, Asia, and Latin America. EndoStim was founded in 2009 and is based in Dallas, Texas.

Kobojo is a French startup that was created in 2008. Kobojo was created to give a social dimension to classical games and online applications, for we love games, most particularly when we can play with friends ! Games for social networks provide much more fun, and a more interesting user experience, for your adversaries are usually people you know ! Kobojo proposes games and applications for social networks, and facilitates the connection between players, for people to play with friends they have not seen for a long time, for instance. Moreover Kobojo’s applications don’t need to be downloaded. Kobojo proposes games for everyone, and despite our games are currently only availabe on Facebook and iPhone, we will soon offer you to play on MySpace, Bebo, Hi5 and many other social networks !

Gynesonics, Inc. designs and develops minimally invasive solutions for symptomatic uterine fibroids in women. The company offers Sonography-Guided Transcervical Fibroid Ablation (Sonata) System(The Sonata System) for the transcervical treatment of symptomatic uterine fibroids under intrauterine sonography guidance serving customers in the European Union. Gynesonics, Inc. was founded in 2005 and is based in Redwood City, California with an additional location in Beuningen, the Netherlands.

Virtual Incision is the pioneer of in vivo mini-robot surgery, enabling minimally-invasive colon resection and other abdominal procedures. Colorectal cancer is the second-deadliest form of the disease, and along with conditions like Diverticulitis and Crohn’s, treatment often requires a colectomy, almost 400,000 of which are performed each year in the U.S. alone. Two-thirds of these procedures are still performed open, requiring a long, gruesome incision. VIC’s simpler/easier/cheaper approach is to insert a mini-robot into the insufflated abdomen via a small umbilical incision, after which the highly-dextrous robot arms are freely manipulated at the nearby surgeon console. VIC enables MIS colectomy using well-known laparoscopic tools, onboard vision, and leading multi-quadrant capabilities. After 70+ pig labs and with 60+ patents/applications, VIC is seeking a $15M Series B financing to achieve First-in-Man and prepare for CE Mark and FDA 510(k) submissions.

IntelyCare offers a digital workforce augmentation platform that combines a gig-model application with advanced data science to optimize staff resources and close the widening gap between workforce supply and demand. IntelyCare is revolutionizing the antiquated healthcare staffing market, filling nursing shifts at three times the industry average and giving post-acute facilities the tools to predict and manage staffing needs. The company’s engaging mobile app empowers nursing professionals with access to flexible, on-demand work opportunities, reducing burnout and attrition while increasing productivity.

Nfocus Neuromedical, Inc. designs, develops, and markets endovascular neurosurgery solutions to cure intracranial aneurysms. The company offers revolutionary systems to treat neurovascular disease, including brain aneurysms. The company was formerly known as CardioVasc, Inc. and changed its name to Nfocus Neuromedical, Inc. in April 2007. The company was incorporated in 1997 and is based in Palo Alto, California. As of February 19, 2013, Nfocus Neuromedical, Inc. operates as a subsidiary of Covidien plc.

SOPHiA GENETICS combines deep expertise in life sciences and medical disciplines with mathematical capabilities in data computing. The company aims to bring data analytics solutions to the market, to support healthcare professionals by maximizing the power of data-driven medicine. It achieves this mission through the adoption of SOPHiA AI, which is built using techniques such as statistical inference, pattern recognition, and machine learning. This enables SOPHiA to provide equal benefits to all users, unite experts in a gold standard health-tech platform, and motivate expert knowledge sharing for a sustainable impact on future patients. It contributes to making the global healthcare system more sustainable. By helping healthcare professionals leverage their expertise and work together as a community, patients can receive equal access to better diagnoses and treatments. It combines the first two pillars of data-driven medicine, genomics, and radionics, the company ensures that the data used to help patients. Founded by Jurgi Camblong, Lars Steinmetz, and Pierre Hutter, SOPHiA GENETICS was incorporated in 2011. It has offices in Boston, Massachusetts, Switzerland, and France.

VertiFlex, Inc., a medical device company, provides minimally invasive and motion preserving spinal surgery technologies in the United States and internationally. The company offers superion interspinous spacer, a percutaneous titanium implant that fits between the spinous processes in the lumbar spine. Its Superion is a motion-preserving interspinous spacer for the treatment of moderate spinal stenosis. Vertiflex Inc was founded in 2005 and is headquartered in California, USA.

Miach Orthopaedics is a medical device company that develops bio-engineered surgical implants to facilitate new tissue growth. The company's product is the Bridge-Enhanced ACL Repair technology as a viable alternative to conventional ACL reconstruction for patients who have withstand an anterior cruciate ligament injury. Miach Orthopaedics was founded on 2016 and is headquartered in Westborough, Massachusetts.

HealthJoy is a first-of-its-kind benefits experience platform helping companies save money while improving employee satisfaction. Through personalized guidance and AI technology, we empower employees to better use and understand their benefits. The result is happier employees, increased cost containment, and fewer questions for HR. HealthJoy integrates a client’s existing benefits to deliver each employee a personalized digital benefits wallet that keeps benefits top-of-mind. Employees also gain on-demand access to online medical consultations, live healthcare concierges, Rx savings, and much more. HealthJoy empowers employees to become educated healthcare shoppers and fundamentally changing the dynamics of healthcare.

VentureMed Group (VMG) designs, develops and markets innovative medical devices which enable interventionalists to cost effectively treat peripheral artery diseases and improve the lives of their patients. Founded by physicians who understand the clinical, medical and financial demands in today’s healthcare environment, VMG creates truly cost effective solutions. Their flagship product, the FLEX Scoring Catheter enables providers to reduce expensive inventory costs while offering the interventionalist more treatment options from a single device.

PneumRx, Inc., a start-up medical device company, develops minimally invasive treatments for emphysema patients. The company develops RePneu Lung Volume Reduction Coil, an investigational device for treating emphysema patients. PneumRx, Inc. was founded in 2004 and is based in Mountain View, California.

Full-service provider in the prepaid and gift card industry and leading network for the distribution of gift cards in continental Europe.

Polares Medical S.A. manufactures and markets medical device to reduce or eliminate mitral valve regurgitation. The company is based in Ecublens, Switzerland, with additional office in Palo Alto, California.

Gynesonics, Inc. designs and develops minimally invasive solutions for symptomatic uterine fibroids in women. The company offers Sonography-Guided Transcervical Fibroid Ablation (Sonata) System(The Sonata System) for the transcervical treatment of symptomatic uterine fibroids under intrauterine sonography guidance serving customers in the European Union. Gynesonics, Inc. was founded in 2005 and is based in Redwood City, California with an additional location in Beuningen, the Netherlands.

They are a clinical-stage nanomedicine platform company developing Accurins™, our novel targeted and programmable therapeutics. Accurins are designed with specified physical and chemical characteristics to target specific cells or tissues and concentrate a therapeutic payload at the site of disease to enhance efficacy while minimizing adverse effects on healthy tissues. Our strategy is to leverage our medicinal nanoengineering platform to develop our own pipeline of Accurins, initially in oncology, as well as Accurins in collaboration with biopharmaceutical companies. Our lead drug candidate, BIND-014, is in Phase 2 clinical trials for non-small cell lung cancer (NSCLC) and metastatic castrate-resistant prostate cancer (mCRPC). To date in 2013, we have announced collaborations with Amgen, Pfizer and AstraZeneca to develop Accurins based on therapeutic payloads from their product pipelines.

Oncoethix SA is a private Swiss company that was founded in 2007 by Esteban Cvitkovic, MD, Kay Noel, PhD, Yves Paternot, and Patrice Herait, MD (all former associates at Cvitkovic & Associes Consultants SA) to develop a portfolio of 3 to 5 promising new drugs for cancer treatment. The company intends to develop its compounds through clinical proof of concept and the identification of an expedited registration strategy, after which pharmaceutical partners will be sought to fund pivotal trials and handle commercialization. Oncoethix founders have an unsurpassed track record in identifying and bringing oncology leads to global markets. Dr. Cvitkovic, Chief Scientific Officer for Oncoethix, led the clinical development of single agent and combination regimens for cisplatin, vindesine, bleomycin, navelbine, and, more recently, irinotecan, oxaliplatin, docetaxel, and trabectedin, first as an academic investigator and then through a specialized oncology clinical research organization. Prior to founding Oncoethix and assuming responsibilities as Chief Operating Officer, Dr. Noel had co-founded another oncology drug development company which in-licensed oxaliplatin as its first portfolio product and subsequently identified, evaluated, and in-licensed novel agents for several clients. Additionally, Dr. Noel has developed expedited registration strategies for many cancer drugs and registration files for a few of these. Dr. Herait managed clinical development of irinotecan, from Phase 1 through Phase 3, while at Rhone Poulenc Rorer and subsequently, as a consultant, managed clinical studies for several novel cancer drugs. Since its founding, Oncoethix has in-licensed three promising cancer drug candidates, each a first-in-class agent to a novel target or with a novel mode of action. Currently, two portfolio compounds are in clinical development. Oncoethix was launched with an initial financing of 1.30 million Swiss francs from the founders to finance portfolio development. In December 2009, the company closed a Series A financing of 3.7 million Swiss francs with leading venture capital firms Index Ventures and Endeavour Vision.

Amplidata N.V. offers AmpliStor, an object-based software defined storage solution for enterprise, private cloud, and public cloud implementations in various industries in Belgium and internationally. The company offers Himalaya Service Provider and OEM Edition software, a customizable platform for service provider and OEM-built storage services and solutions; and Himalaya Enterprise Edition software, which provides users with control over their data. It also offers a range of appliances that include the AmpliStor software with servers, as well as controllers and storage nodes connected through a standard switched Ethernet fabric. In addition, the company provides support and professional services for large enterprises, service provides, and distributed government organizations. It offers solutions for cloud services, life sciences, media and entertainment, oil and gas, online applications, digital library, video surveillance, government, and Fortune 500 enterprises. Amplidata N.V. has a strategic partnership with Western Digital Capital. The company was founded in 2008 and is based in Lochristi, Belgium with an additional headquarters in Milpitas, California. It also has support centers in the United States, Belgium, and Taiwan. Amplidata N.V. operates as a subsidiary of HGST Netherlands B.V.